Degenerative Disc Disease Treatment Market Report, Size, Share, Growth, Trends, Industry Forecast to 2033

"Gain a competitive edge with up to 30% off in-depth market reports-uncover key trends, growth drivers, and forecasts today!

The new report published by The Business Research Company, titled Degenerative Disc Disease Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the degenerative disc disease treatment market size has grown strongly in recent years. It will grow from $25.33 billion in 2023 to $27.07 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The degenerative disc disease treatment market size is expected to see strong growth in the next few years. It will grow to $35.45 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%.

Download Free Sample Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=18784&type=smp

What Is Driving The Growth Of The Global Degenerative Disc Disease Treatment Market?

Rising Sports And Back Injuries Drive Growth In Degenerative Disc Disease Treatment Market
Rising sports injuries are expected to propel the growth of the degenerative disc disease treatment market going forward. Sports injuries refer to physical damage or trauma sustained by athletes or individuals engaging in physical activities, often resulting from sudden impacts, overuse, or improper techniques. The increase in sports injuries is often attributed to factors such as higher participation rates, more intense training regimens, and a greater emphasis on competitive performance. Degenerative disc disease treatment is used in sports injuries to manage chronic spinal pain and restore function when disc degeneration impacts athletes' performance and mobility. For instance, in June 2022, according to the National Safety Council, a US-based nonprofit public service organization, 3.2 million people were treated in emergency departments for injuries involving sports and recreational equipment. The number of injuries increased by 20% in 2021, with 409,224 injuries in 2021 compared to 377,939 in 2020. Therefore, the rising sports injuries are driving the growth of the degenerative disc disease treatment market.

What Is The Key Trend In The Global Degenerative Disc Disease Treatment Market?

Injectable Disc Cell Therapy (IDCT) Advances With FDA Designation
Major companies operating in the degenerative disc disease treatment market are focusing on developing novel therapies, such as injectable disc cell therapy (IDCT), to improve patient outcomes by increasing disc volume, alleviating low back pain, and reducing dependence on pain medications. The regenerative treatment, injectable disc cell therapy (IDCT), targets symptomatic lumbar degenerative disc disease. For instance, in February 2023, DiscGenics Inc., a US-based biopharmaceutical company, received FDA regenerative medicine advanced therapy designation for its injectable disc cell therapy (IDCT), aimed at treating symptomatic lumbar degenerative disc disease. This innovative therapy uses a live progenitor cell population derived from donated adult human intervertebral disc tissue. IDCT has the potential to increase disc volume, alleviate low back pain, and reduce the need for pain medication in affected patients.

How Is The Global Degenerative Disc Disease Treatment Market Segmented?
The degenerative disc disease treatment market covered in this report is segmented -

1) By Type: Conventional Drugs, Novel Therapies
2) By Route Of Administration: Oral, Injectable
3) By End User: Hospitals, Ambulatory Surgical Centers, Orthopedic Center

You Can Pre-Book The Global Market Report Of Your Requirement For A Swift Delivery And Also Get An Exclusive Discount On This Report, Checkout Link:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18784

How Is The Competitive Landscape Of The Global Degenerative Disc Disease Treatment Market?
Major companies operating in the degenerative disc disease treatment market are Pfizer Inc., Johnson And Johnson, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Medtronic plc, Amgen Inc., Baxter International Inc., B. Braun SE, Zimmer Biomet Holdings Inc., Arthrex Inc., Ferring B.V., Biocon Limited, Integra LifeSciences Holdings Corporation, NuVasive Inc., Globus Medical Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., LifeNet Health

Contents Of The Global Degenerative Disc Disease Treatment Market
1. Executive Summary
2. Degenerative Disc Disease Treatment Market Report Structure
3. Degenerative Disc Disease Treatment Market Trends And Strategies
4. Degenerative Disc Disease Treatment Market - Macro Economic Scenario
5. Degenerative Disc Disease Treatment Market Size And Growth
…..
27. Degenerative Disc Disease Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore The Report Store To Make A Direct Purchase Of The Report: https://www.thebusinessresearchcompany.com/report/degenerative-disc-disease-treatment-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.